Implanet SA
PAR:ALIMP

Watchlist Manager
Implanet SA Logo
Implanet SA
PAR:ALIMP
Watchlist
Price: 0.256 EUR 4.92% Market Closed
Market Cap: €36.7m

Net Margin

-43.3%
Current
Improving
by 15.4%
vs 3-y average of -58.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-43.3%
=
Net Income
€-4.8m
/
Revenue
€11.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-43.3%
=
Net Income
€-4.8m
/
Revenue
€11.1m

Peer Comparison

Country Company Market Cap Net
Margin
FR
Implanet SA
PAR:ALIMP
36.7m EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.5B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.8B USD
Loading...

Market Distribution

Lower than 84% of companies in France
Percentile
16th
Based on 2 398 companies
16th percentile
-43.3%
Low
-147 400% — -2.2%
Typical Range
-2.2% — 7.1%
High
7.1% — 14 243.8%
Distribution Statistics
France
Min -147 400%
30th Percentile -2.2%
Median 2.6%
70th Percentile 7.1%
Max 14 243.8%

Implanet SA
Glance View

Market Cap
36.7m EUR
Industry
Health Care

Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.

ALIMP Intrinsic Value
0.078 EUR
Overvaluation 69%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-43.3%
=
Net Income
€-4.8m
/
Revenue
€11.1m
What is Implanet SA's current Net Margin?

The current Net Margin for Implanet SA is -43.3%, which is above its 3-year median of -58.7%.

How has Net Margin changed over time?

Over the last 3 years, Implanet SA’s Net Margin has increased from -51.1% to -43.3%. During this period, it reached a low of -89.6% on Dec 31, 2023 and a high of -43.3% on Jul 30, 2025.

Back to Top